Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Perceived Stress Scale × Tumor-Agnostic × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 22 Specimen Handling 20 Biopsy 19 Magnetic Resonance Spectroscopy 17 Paclitaxel 11 Nivolumab 10 Bevacizumab 10 Carboplatin 9 Blood Specimen Collection 9 atezolizumab 8 Standard of Care 8 Oxaliplatin 8 Capecitabine 8 Cisplatin 7 Surveys and Questionnaires 6 Pemetrexed 6 Leucovorin 6 Gemcitabine 6 Fluorouracil 6 trastuzumab deruxtecan 5 Taxes 5 Irinotecan 5 Interviews as Topic 5 Cyclophosphamide 5 tislelizumab 4 niraparib 4 Focus Groups 4 Drug Therapy 4 Docetaxel 4 relatlimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07326800 2026-04-16

MAEva-MCT

Institut de Cancérologie de Lorraine

Phase NA Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡